Sector › Medicine
Press Releases
TOPVISION Transfers From LEAP Market To ACE Market, Signs Underwriting Agreement With Hong Leong Investment Bank
TOPVISION Eye Specialist Bhd
Oct 29, 2024 17:30 HKT/SGT
Machine learning can predict the mechanical properties of polymers
Science and Technology of Advanced Materials
Oct 26, 2024 23:08 JST
Founder of Hua Medicine Dr. Chen Li was awarded the 'C.C. Tan Life Science Industrialization Award'
Hua Medicine
Oct 25, 2024 09:18 HKT/SGT
HighTide Therapeutics to Present Analyses of Phase 2 MASH Study at AASLD's The Liver Meeting 2024
HighTide Therapeutics Inc.
Oct 25, 2024 08:57 HKT/SGT
T.MAN Pharmaceutical PCL (SET: TMAN) Showcases Leadership in Health Innovation, Aiming for Sustainable Growth Following Listing on SET
T.MAN Pharmaceutical PCL
Oct 23, 2024 09:00 HKT/SGT
GJK Facility Services Hosts Educational Session With Dr. Chantel Thornton During Breast Cancer Awareness Week
GJK Facility Services
Oct 23, 2024 07:00 HKT/SGT
Positive Partial 12-Week Body Weight Results from Lexaria's GLP-1 Diabetes Animal Study
Lexaria Bioscience
Oct 22, 2024 21:20 HKT/SGT
ONERHT Foundation Celebrates 9th Charity Golf and Gala Dinner Event, Raising Over S$430,000 to Support 9 Charitable Organisations
ONERHT Foundation
Oct 22, 2024 18:00 JST
Femto Technologies Inc. Announces Consolidation of Enhanced Voting Preference Shares
Femto Technologies Inc
Oct 22, 2024 08:00 HKT/SGT
Acrometa Group to Divest Its Life Sciences Business, Pursue New Business Opportunities in the Region
AcroMeta Group Limited
Oct 21, 2024 22:50 HKT/SGT
China Medical System: First Ruxolitinib Cream's Prescriptions for Vitiligo Issued in the Greater Bay Area
China Medical System Holdings Ltd.
Oct 21, 2024 10:00 HKT/SGT
A Joint Regional Cohort Study by Shimadzu, Eisai, Oita University, and Usuki City Medical Association
Eisai
Oct 17, 2024 19:01 HKT/SGT
Update on Regulatory Review of Lecanemab for Early Alzheimer's Disease in Australia
Eisai
Oct 17, 2024 14:59 HKT/SGT
Athos宣佈其人工智慧生成的全新口服G9A抑製劑ATH-063的I期臨床試驗頂線數據，顯示其對強效抗炎調節性T細胞的選擇性擴增和啟動
Athos Therapeutics, Inc
Oct 17, 2024 08:00 HKT/SGT
Athos宣布其人工智能生成的全新口服G9A抑制剂ATH-063的I期临床试验顶线数据，显示其对强效抗炎调节性T细胞的选择性扩增和激活
Athos Therapeutics, Inc
Oct 17, 2024 08:00 HKT/SGT
Athos Announces Positive Topline Phase 1 Data for its AI-Generated, Novel, Oral G9A Inhibitor ATH-063, Demonstrating Selective Expansion and Activation of Potent Anti-Inflammatory Regulatory T Cells
Athos Therapeutics, Inc
Oct 17, 2024 08:00 HKT/SGT